Intercontinental Exchange Expands India Footprint with Major Pune GCC – A Strategic Signal for the Next Wave of Global Capability Investments
Pharma and Life Sciences GCCs cut drug timelines by 1–2 years and drive a 5% decline in R&D-to-launch costs